Full-service CRO, with a Phase I Clinical Research Unit, providing clinical trials full-package
Total Trials
6
As Lead Sponsor
1
As Collaborator
5
Total Enrollment
371
NCT02541721
Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses
Phase: N/A
Role: Collaborator
Start: Sep 30, 2015
Completion: Jan 31, 2018
NCT02777489
Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects
Phase: Phase 2
Start: Feb 18, 2016
Completion: Apr 27, 2017
NCT03224338
Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects
Role: Lead Sponsor
Start: Apr 5, 2017
Completion: Jul 2, 2019
NCT04505137
A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers
Phase: Phase 1
Start: Sep 2, 2020
Completion: Mar 19, 2021
NCT06345677
Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects
Start: Jun 9, 2023
Completion: Feb 1, 2024
NCT06719089
Evaluation of the Safety and Performance of the Hydrustent® Biodegradable Hydrogel Ureteral Stent
Start: Jul 1, 2025
Completion: Dec 31, 2026
Loading map...